A
Aldeyra Therapeutics (ALDX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aldeyra Therapeutics (ALDX)
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dr... Read more
- USD3.79
- USD4.04
- USD3.73
- USD7.20
- 85.40%
- --
- 1.49k
- 922.94k
- 227M
- 1.14
- 20.90%
Stock News
40 minutes ago
Centene’s Medicaid business and healthcare costs are a problem, and its stock plunges
MarketWatch
55 minutes ago
ADP says economy loses jobs for the first time since 2023 due to trade wars
MarketWatch
1 hour ago
Gen Z is grappling with global chaos—here's how they're coping with 'inheriting broken systems'
CNBC
2 hours ago
Unum America closes reinsurance transaction with Fortitude Re
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
